Alivus Life Sciences Ltd (ALIV)

Currency in INR
1,350.90
-19.10(-1.39%)
Closed·

ALIV Earnings

Latest Release
Jul 30, 2026
EPS / Forecast
13.00 / --
Revenue / Forecast
6.4B / 6.68B
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/09--/9.40--/------Free Sign Up
2026/0613.00/--6.40B/6.68B---4.19%Free Sign Up
2026/0314.10/--6.89B/6.55B--+5.19%Free Sign Up
2025/1212.75/--6.73B/6.74B---0.15%Free Sign Up
2025/0910.60/9.405.88B/6.00B+12.77%-2%Free Sign Up
2025/069.88/10.806.02B/6.47B-8.52%-6.96%Free Sign Up
2025/0311.60/--6.50B/------Free Sign Up
2024/1211.14/12.566.42B/5.90B-11.31%+8.81%Free Sign Up
2024/097.60/7.405.07B/5.07B+2.7%0%Free Sign Up
2024/068.90/8.905.89B/5.89B0%0%Free Sign Up

All numbers in INR

Alivus Life Sciences Ltd Earnings Call Summary for Q1/2027

  • Q1 revenue rose 6.4% YoY to INR 640 crores; EBITDA margin expanded 650 bps to 36.6% despite 52.6% drop in GPL sales
  • Non-GPL business surged 26.5% driven by new launches; gross margin improved 510 bps to 60.2% on favorable product mix
  • Company maintained FY 2027 revenue growth guidance of 10%-12%, expecting stronger H2 performance with margin target of 30%-32%
  • Alivus remains debt-free with INR 880 crores cash; capacity expansions at Dahej and Ankleshwar on track to support growth
  • Pipeline includes 29 high-potent APIs targeting $82B market; patent expiries begin late 2027 with commercialization in FY 2028
Last Updated: 2026-07-31, 12:56 a/m
Read Full Transcript

FAQ

What Is Alivus Life Sciences's Earnings Per Share (TTM)?

The Alivus Life Sciences EPS (TTM) is 49.03.

When Is The Next Alivus Life Sciences Earnings Date?

Alivus Life Sciences will release its next earnings report on Nov 05, 2026.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.